Spravato® (esketamine) is an FDA-approved nasal spray used to treat treatment-resistant depression, covered by many insurance plans. Intramuscular Ketamine is administered via injection directly into the muscle, offering rapid relief from depressive symptoms. While both treatments utilize ketamine's therapeutic effects, their administration methods and insurance coverage differ, with Intramuscular Ketamine typically not covered by insurance.

While ketamine itself is FDA-approved for anesthesia, intramuscular use for depression is considered "off-label." However, a significant body of research and clinical experience has demonstrated its safety and effectiveness for this purpose. Intramuscular ketamine treatments are widely accepted in the medical community as a valuable option for individuals with treatment-resistant depression. Our clinic adheres to strict safety protocols and monitoring to ensure the well-being and comfort of our clients throughout the treatment process.

During the session, you may experience a range of sensations, including relaxation, changes in perception, or a dissociative experience, which are normal and temporary. The treatment room is designed to maximize your comfort, equipped with leather recliners, dimmed lights, and a calm atmosphere. After the treatment, clients typically feel a sense of calm and well-being. Side effects like nausea or increased blood pressure are monitored and managed by our staff. Post-treatment, clients often report improvements in their mood and outlook.

The treatment process begins with a comprehensive consultation to understand your specific needs and to craft a personalized treatment plan. During each session, ketamine is injected intramuscularly by a healthcare professional in a controlled, safe environment. You'll remain in a comfortable, monitored setting for about 2 hours while the effects of the ketamine are observed. Our staff will check your vital signs periodically and ensure you're responding well to the treatment.

Intramuscular Ketamine is a method of administering ketamine directly into the muscle, allowing for rapid absorption into the bloodstream. Ketamine is known for its fast-acting relief of depressive symptoms, especially in individuals who have not responded to traditional treatments. It works by binding to NMDA receptors in the brain, which helps to increase the amount of a neurotransmitter called glutamate. This triggers changes in the brain circuits involved in mood regulation and depression, often resulting in significant improvement in symptoms.